(RTTNews) - Evoke Pharma (EVOK) announced that U.S. Patent No. 12,377,064 for GIMOTI - metoclopramide, nasal spray, used to treat moderate to severe gastroparesis, has been added to the FDA's Orange ...
The CDMO Sector Holds a Core Position in the Pharmaceutical Industry As a major part of the outsourcing pharmaceutical service industry, CDMOs support pharmaceutical companies across the entire chain, ...
LEO Pharma A/S, a global leader in medical dermatology, today announced new long-term results from EFFISAYIL® ON, an ongoing five-year open-label extension study of the pivotal EFFISAYIL 1 trial and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results